VERONA Results Roche

Mikkael A. Sekeres: Top Line VERONA Results – No Advantage to AZA + VEN Compared to AZA Alone for HR-MDS

Mikkael A. Sekeres, Chief, Division of Hematology at Sylvester Comprehensive Cancer Center, shared on X:

“Wow – top line VERONA results are negative – no advantage to AZA + VEN compared to AZA alone for higher-risk MDS. AZA or DAC alone remain the standard for HR-MDS. So disappointing.”

Read Full Article.

More posts featuring Mikkael A. Sekeres.

AZA AZA + VEN cancer higher-risk MDS Mikkael A. Sekeres OncoDaily Oncology VERONA Results